EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeted therapies for urothelial carcinoma: From FGFR inhibitors to next‑generation antibody-drug conjugates (Review)

Jinping Du, Hao Shen, Tongwei Zeng, Wei Liu, Yongqiang Xie

International Journal of Oncology · 2025

DOI: 10.3892/ijo.2025.5841 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2025. Verfasst von Jinping Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, P.R. China. Hauptthemen laut MEDLINE: Immunoconjugates, Protein Kinase Inhibitors, Molecular Targeted Therapy, Receptors, Fibroblast Growth Factor. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesProtein Kinase InhibitorsMolecular Targeted TherapyReceptors, Fibroblast Growth FactorUrinary Bladder NeoplasmsCarcinoma, Transitional CellHumansDrug Resistance, NeoplasmReceptor, Fibroblast Growth Factor, Type 3Biomarkers, TumorAntibodies, MonoclonalTumor MicroenvironmentPyrazolesQuinoxalines

Stichwörter der Autor:innen

antibody‑drug conjugatesbiomarkersfibroblast growth factor receptor inhibitorsprecision medicineresistance mechanismstargeted therapytherapeutic strategiesurothelial carcinoma

Substanzen

ImmunoconjugatesProtein Kinase InhibitorsReceptors, Fibroblast Growth FactorReceptor, Fibroblast Growth Factor, Type 3FGFR3 protein, humanBiomarkers, TumorerdafitinibAntibodies, MonoclonalPyrazolesQuinoxalines

Autor:innen und Institutionen

  • Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, P.R. China.

Zitieren

APA

Du, J., Shen, H., Zeng, T., Liu, W., & Xie, Y. (2025). Targeted therapies for urothelial carcinoma: From FGFR inhibitors to next‑generation antibody-drug conjugates (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2025.5841

Vancouver

Du J, Shen H, Zeng T, Liu W, Xie Y. Targeted therapies for urothelial carcinoma: From FGFR inhibitors to next‑generation antibody-drug conjugates (Review). International Journal of Oncology. 2025. doi:10.3892/ijo.2025.5841

BibTeX
@article{Du2025,
  author = {Du, Jinping and Shen, Hao and Zeng, Tongwei and Liu, Wei and Xie, Yongqiang},
  title = {Targeted therapies for urothelial carcinoma: From FGFR inhibitors to next‑generation antibody-drug conjugates (Review)},
  journal = {International Journal of Oncology},
  year = {2025},
  doi = {10.3892/ijo.2025.5841}
}
Kostenlos starten →